XELODA Reimbursement

When used for anti-cancer chemotherapy, XELODA is eligible for coverage under:
Traditional Medicare Part B as well as under other Medicare Health Plans, including Medicare Advantage plans.
 
Reimbursement Support for Your Oncology Practice at
 
XELODAreimbursement.com
 
A comprehensive resource from Roche Oncology to support healthcare professionals and their staff through the Medicare reimbursement process for XELODA® (capecitabine).
 
This site offers XELODA-related information on:

• Medicare coverage policy
• Claim filing requirements, coding, and billing
• General billing, coding, payment information
• Current Medicare Part B Reimbursement Allowances for XELODA
• Oncoline Reimbursement Hotline

Medicare Coverage Policies

• Medicare DMEMAC specific coverage policies
• Links to relevant content within the CMS site

 
ONCOLINE Reimbursement Hotline and Patient Assistance Program for XELODA
The Roche reimbursement hotline both professionals and patients to valuable patient assistance resources. For answers to your billing, reimbursement, and coverage policy questions, ONCOLINE Reimbursement Hotline can help!
 
 
Clinical Information support: Our knowledgeable specialists prepare comprehensive medical information searched concerning Roche oncology products.
Reimbursement Hotline: Oncoline will research individual payer requirements and provide information to help you obtain reimbursement.